ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 382049 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 382049; 2) Community: the network communities that were significantly associated with the response to NSC 382049; 3) Molecule: the relationships between components within communities and NSC 382049; 4) MDR: the compounds that were significantly associated with the NSC 382049.

NSC Compound Enrichment Correlation
NSC 714379 Null 0.00457614317494024 0.33391694
NSC 71669 Null 0.00457614317494024 0.71430792
NSC 720299 Methyl-7.alpha.,12.alpha.-diacetoxy-5.beta.-cholan-24-oate-~ 3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclo pentane 0.00457614317494024 0.40940026
NSC 728038 2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline 0.00457614317494024 0.20165704
NSC 735030 Null 0.00457614317494024 0.32840472
NSC 736041 7-(5-diethylaminopentyloxy)-5-hydroxy-2-phenyl-4H-4-chromeno ne 0.00457614317494024 0.35163135
NSC 740 Methotrexate 0.00457614317494024 0.82072684
NSC 740024 4-(2-Benzylthio-4-chloro-5-methylbenzenesulfonyl)-5,7-dimeth yl-2,4-dihydro-[1,2,4]triazepin-3-ylideneamine 0.00457614317494024 0.34209942
NSC 744063 Null 0.00457614317494024 0.43275921
NSC 79093 5-Hydroxy-6,7,8,4'-tetramethoxyflavone 0.00457614317494024 0.34091091
Total:136  Current:22    [First] [Prev] [Next] [Last]